Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Not applicableStudy completedNCT04353765What this trial is testingStudy Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint InhibitorsWho this might be right forLocally Advanced or Metastatic Renal Cell Carcinoma Ipsen 247
Testing effectiveness (Phase 2)Looking for participantsNCT06682793What this trial is testingEvaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more A2 Biotherapeutics Inc. 240
Testing effectiveness (Phase 2)Study completedNCT00609401What this trial is testingStudy Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)Who this might be right forMetastatic DiseaseRenal Cell Carcinoma Italian Trial in Medical Oncology 90
Testing effectiveness (Phase 2)Ended earlyNCT00684996What this trial is testingBevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forRecurrent Renal Cell CancerRenal Cell CarcinomaStage III Renal Cell Cancer+1 more National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090What this trial is testingSavolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCCWho this might be right forPapillary Renal Cell Carcinoma AstraZeneca 148
Testing effectiveness (Phase 2)UnknownNCT00024388What this trial is testingChemotherapy in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Theradex
Testing effectiveness (Phase 2)WithdrawnNCT00040989What this trial is testingBAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney CancerWho this might be right forStage IV Renal Cell CancerRecurrent Renal Cell Cancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00027573What this trial is testingChemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)Study completedNCT02915783What this trial is testingA Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced DiseaseWho this might be right forNon Clear Cell Renal Cell Carcinoma (nccRCC) Eisai Inc. 41
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03945773What this trial is testingStudy of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint InhibitorsWho this might be right forLocally Advanced or Metastatic Renal Cell Carcinoma Ipsen 127
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Not applicableStudy completedNCT01210482What this trial is testingTemsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)Who this might be right forRenal Cell Carcinoma Pfizer 1,050
Not applicableStudy completedNCT03663946What this trial is testingObserve the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has SpreadWho this might be right forRenal Cell CarcinomaKidney Cancer Bristol-Myers Squibb 81
Large-scale testing (Phase 3)Study completedNCT00005966What this trial is testingInterferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group
Very early researchLooking for participantsNCT07645690What this trial is testingThe Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forUnresectable or Metastatic Clear Cell Renal Cell Carcinoma Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00601926What this trial is testingBevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer Paul Monk 5
Testing effectiveness (Phase 2)Ended earlyNCT03334409What this trial is testingPazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more Academic and Community Cancer Research United 5
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105